Systemic scleroderma, A clinical study of 727 cases

scientific article published on 01 September 1961

Systemic scleroderma, A clinical study of 727 cases is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/ARCHDERM.1961.01580150005001
P698PubMed publication ID13778561

P2093author name stringR K WINKELMANN
D L TUFFANELLI
P921main subjectsystemic sclerodermaQ5340515
P304page(s)359-371
P577publication date1961-09-01
P1433published inArchives of DermatologyQ15749524
P1476titleSystemic scleroderma, A clinical study of 727 cases
P478volume84

Reverse relations

cites work (P2860)
Q41731448Absence of oesophageal mucosal folds in systemic sclerosis
Q35143907Acute Scleroderma (morphoea) with Myositis
Q71097853Anaemia due to blood loss from the telangiectases of scleroderma
Q35117202Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study.
Q34236081Autoantibodies and overlap syndromes in autoimmune rheumatic disease
Q71557922Autoantibodies to the heat-shock protein hsp73 in localized scleroderma
Q47925692Autoimmune Haemolytic Anaemia with Positive Ham and Crosby's Test and Scleroderma: A Case Report
Q69779323Avascular necrosis of the femoral head in long-term follow-up of systemic sclerosis: report of two cases
Q76677074CHRONIC DISEASE OF THE LIVER ASSOCIATED WITH SYSTEMIC SCLERODERMA
Q35896510CURRENT CONCEPTS IN DERMATOLOGY. II. THE SKIN AND SYSTEMIC DISEASE
Q35437082CURRENT CONCEPTS OF THE PATHOGENESIS OF THE SO-CALLED COLLAGEN DISEASES.
Q42006360Case of mixed connective tissue disease associated with autoimmune hepatitis
Q41122085Central retinal vein occlusion and scleroderma: implications for sclerodermatous vascular disease
Q34152922Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis
Q40697280Classification of scleroderma
Q72196962Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma
Q67472028Clinical evaluation of scleroderma spectrum disorders using a points system
Q70232740Clinical profiles of patients with antibodies to nuclear ribonucleoprotein
Q33551496Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA)
Q85023043Close association of anti-U1 ribonucleoprotein antibody with drug allergy in patients with connective tissue diseases
Q72554756Color Changes in the Extremities as They Relate to Peripheral Vascular Disease
Q40611361Condylysis in a patient with a mixed collagen vascular disease
Q71821906Connective tissue diseases
Q37594898Connective tissue ulcers
Q72130260Current concepts in the classification of connective tissue diseases. Overlap syndromes and mixed connective tissue disease (MCTD)
Q72268809Cutaneous Manifestations of Gastrointestinal Disease
Q72788575Cutaneous signs (Raynaud's phenomenon, sclerodactylia, and edema of the hands) and hand-arm vibration exposure
Q72269085Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma
Q33570128Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting
Q72230312Diffuse systemic sclerosis with abnormal liver and gall bladder
Q49159854Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis
Q71267975Electrocardiographic examination in patients with skin diseases
Q39476745Electrophysiological evidence of "nerve entrapment syndromes" and subclinical peripheral neuropathy in progressive systemic sclerosis (scleroderma).
Q40031365Entero-arthropathy: The Coexistence of Articular and Gastrointestinal Manifestations in Systemic Disease
Q29036024Eosinophilic fasciitis. Case report and review of the literature
Q33631736Epidemiology of scleroderma
Q71448553Esophageal Motility
Q35687801Esophageal involvement in scleroderma: clinical, endoscopic, and manometric features
Q55982204Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis
Q42739520GENERALIZED MORPHOEA.
Q39115954Gastroesophageal Reflux in Esophageal Scleroderma: Diagnosis and Implications
Q73364623HLA‐B8 in Raynaud's Phenomenon
Q35553844Hepatic manifestations of autoimmune rheumatic diseases
Q39822728Hepatocyte giant mitochondria: An almost constant lesion in systemic scleroderma
Q71006450Hereditary hemorrhagic telangiectasia versus CREST syndrome: can serology aid diagnosis?
Q73520766Idiopathic inflammatory myopathies
Q39830587Immune complex nephropathy in mixed connective tissue disease
Q48587777Impaired quantitative cerebral blood flow in scleroderma patients
Q34493242Increased C1q binding and arthritis in primary biliary cirrhosis
Q34374484Juvenile systemic scleroderma
Q67599142Long-term follow-up study of 164 patients with definite systemic sclerosis: classification considerations
Q40528990Lymphokine stimulation of collagen accumulation
Q39351914Management of sclerodermal finger ulcers
Q39859237Membranoproliferative glomerulonephritis in systemic sclerosis of childhood
Q47660081Microvascular involvement in Systemic Sclerosis and Systemic Lupus Erythematosus.
Q69388522Mixed connective tissue disease
Q33631754Mixed connective tissue disease, overlap syndromes, and eosinophilic fasciitis
Q36376858Morbidity and mortality of patients diagnosed with systemic sclerosis after the age of 75: a nested case-control study
Q51551268Multiple avascular necrosis in a patient with systemic lupus erythematosus/systemic sclerosis overlap syndrome.
Q34407876Muscle abnormalities in scleroderma
Q46256178Muscle involvement in systemic sclerosis: points to consider in clinical trials
Q84850103Necrotizing fasciitis in a patient with overlap syndrome of systemic sclerosis and systemic lupus erythematosus
Q39644827Neoplastic associations of rheumatic diseases and rheumatic manifestations of cancer.
Q37879776Neurological complications of systemic sclerosis--a report of three cases and review of the literature
Q40207637Neuropsychiatric problems in mixed connective tissue disease
Q41220150Occupational and environmental influences on scleroderma
Q72255724Oesophageal motility in connective tissue disease
Q72814441Oesophageal motility studies
Q33995782Ophthalmic manifestations of progressive systemic sclerosis
Q33579824Osteodysplasty (Melnick and Needles syndrome). Report of a case
Q78229093PROGNOSIS IN RAYNAUD'S PHENOMENON AFTER SYMPATHECTOMY
Q55315342Pancytopenia and scleroderma
Q41069217Pathogenesis of systemic sclerosis: A vascular hypothesis
Q39794476Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: successful treatment of two patients and a review of the literature
Q70168385Peripheral neuropathy in course of progressive systemic sclerosis. Light and ultrastructural study
Q41628384Peripheral neuropathy in the course of progressive systemic sclerosis: light and ultrastructural study
Q54507112Polymyositis associated with several immunological disorders.
Q81841532Predictive value of nailfold capillaroscopy in patients with Raynaud's phenomenon
Q42093945Prevalence and clinical relevance of 52-kDa and 60-kDa Ro/SS-A autoantibodies in Japanese patients with systemic sclerosis
Q77676693Prevalence of impaired gastric emptying of solids in systemic sclerosis: diagnostic and therapeutic implications
Q35603089Primary B-cell lymphoma of the tongue in a patient with systemic sclerosis
Q35609106Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges.
Q33579829Prodromal trigeminal sensory neuropathy in progressive systemic sclerosis
Q44274898Prognosis of generalized scleroderma. A retrospective study of 78 cases
Q71456178Progressive Systemic Sclerosis (Scleroderma)
Q41625669Proximal stomach and antrum in stomach emptying
Q39530587Pyloric stenosis in a patient with progressive systemic sclerosis
Q33356119RENAL VASCULAR DISEASE.
Q34352783Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literature.
Q35637515Radiological hand involvement in systemic sclerosis
Q70489439Raynaud's disease
Q33631731Raynaud's phenomenon: its relevance to scleroderma
Q34385471Recognition and management of scleroderma in children
Q73335112Refractory Raynaud's phenomenon in scleroderma: an indication for surgery
Q73024605Relationships between electrocardiographic and echocardiographic findings in systemic sclerosis (scleroderma)
Q49375225Resolution of cutaneous manifestations of systemic sclerosis after haemodialysis
Q33568738Respiratory function in systemic lupus erythematosus, scleroderma, and rheumatoid arthritis
Q39552991Reverse transcriptase in a patient with scleroderma
Q74571075Rheumatic diseases and malignancy--is there an association?
Q40513147Rheumatoid arthritis and connective tissue disorders: India and South-East Asia
Q66880580Scleroderma
Q44530975Scleroderma (Progressive Systemic Sclerosis): progress and course based on a personal series of 118 cases
Q33553581Scleroderma and erosive polyarthritis: a disease entity?
Q33565616Scleroderma and malignancy: an epidemiological study
Q72650201Scleroderma and motor neuron disease: an unusual association
Q71371699Scleroderma and other diseases associated with cutaneous sclerosis
Q56008640Scleroderma and primary biliary cirrhosis
Q41333515Scleroderma and related conditions
Q33563548Scleroderma and survival
Q35939760Scleroderma and the kidney
Q38020677Scleroderma esophagus
Q35151855Scleroderma in childhood. Report of 5 cases
Q70025625Scleroderma in the child
Q71817226Scleroderma in the elderly, with special reference to the CRST syndrome
Q33765558Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology
Q67653673Sclerosis of the intestinal tract with severe malabsorption
Q33722916Screening for cancer in the patient with rheumatic disease
Q38070319Seizures in systemic sclerosis
Q69590497Specificity and sensitivity of esophageal motor abnormality in systemic sclerosis (scleroderma) and related diseases: a cineradiographic study
Q71015931Surgical management of scleroderma reflux esophagitis
Q72104104Surgical presentation of systemic sclerosis of the small intestine
Q40809160Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran
Q33567971Survival in scleroderma
Q45337964Survival with scleroderma—II: A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients
Q64974174Systemic lupus erythematosus: a report of forty-five cases with unusual clinical and immunological features
Q41790524Systemic scleroderma and malignant diseases. A review of the literature
Q35549272Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele.
Q39634078Systemic scleroderma. Clinical and pathophysiologic aspects
Q43858585Systemic sclerosis and cryoglobulinemia
Q73181326Systemic sclerosis and scleroderma renal crisis in association with carcinoma of the breast
Q35004032Systemic sclerosis and small bowel involvement
Q33594498Systemic sclerosis associated with colliquative necrosis in the cerebellum
Q33566531Systemic sclerosis in Iceland. A nationwide epidemiological study
Q57651740Systemic sclerosis in old age
Q67992439Systemic sclerosis in the elderly
Q42020247Systemic sclerosis sine scleroderma presenting with vitiligo-like depigmentation and interstitial pulmonary fibrosis
Q35898408Telangiectases simulating hereditary hemorrhagic telangiectasia in scleroderma. Report of two cases
Q36771906The Raynaud syndrome
Q39932900The Rheumatic Diseases in Adolescence
Q33551584The arthritis of mixed connective tissue disease
Q33553587The articular manifestations of progressive systemic sclerosis (scleroderma).
Q36722268The diagnosis and classification of scleroderma (systemic sclerosis)
Q40697329The diagnosis of Raynaud's phenomenon
Q41220252The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanisms
Q35897751The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease
Q39941874The rheumatic diseases of childhood
Q44448148The significance of an air oesophagogram visualised on conventional chest radiographs
Q70786234The skin changes in scleroderma (systemic sclerosis)
Q43739773The systemic involvement in scleroderma
Q35309080Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22.
Q69700736Treatment of scleroderma skin ulcers with a hydrocolloid membrane
Q67863951Trigeminal sensory-neuropathy in systemic sclerosis
Q76562423URINARY 5-HYDROXYINDOLEACETIC ACID EXCRETION IN SCLERODERMA
Q94325515Ultraviolet autorepigmentation in scleroderma
Q44901834Unusual case of progressive systemic sclerosis with onset in early childhood and following infectious mononucleosis
Q36806259Vascular leak is a central feature in the pathogenesis of systemic sclerosis
Q80052072[Autoimmune hepatitis and morphea: a rare association]
Q78046768[Involvement of the small intestine in systemic scleroderma]
Q79601482[Peculiarities in progressive scleroderma]
Q73245714[Pulmonary involvement in systemic scleroderma. Part I. Chronic fibrosing interstitial lung disease]

Search more.